Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

BKLNBKLN
25 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in INVESCO EXCH TRADED FD TR II

Qube Research & Technologies Ltd holds 17,257 shares of BKLN (INVESCO EXCH TRADED FD TR II), worth $351,525 as of 2026-Q2. The position was increased (+7.6% shares). BKLN represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$351,525

Current Shares

17,257

Total Value Change

+$327,525

Total Shares Change

+16,198

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
17,257
+7.6%
$351,5250.0%$20.26
25
2026-Q1
Decreased
16,040
-66.7%
$327,3760.0%$20.00
0
2025-Q4
Increased
48,207
+1.2%
$1M0.0%$20.26
25
2025-Q3
Increased
47,628
+37.8%
$996,8540.0%$19.86
33
2025-Q2
Decreased
34,555
-27.7%
$722,8910.0%$19.51
0
2025-Q1
Increased
47,782
+42.8%
$989,0870.0%$18.93
34
2024-Q4
Decreased
33,467
-16.0%
$705,1500.0%$18.95
0
2024-Q3
Increased
39,829
+42.7%
$836,8070.0%$18.53
33
2024-Q2
Decreased
27,908
-69.9%
$587,1840.0%$18.13
0
2024-Q1
Increased
92,712
+102.1%
$2M0.0%$17.84
42
2023-Q4
Decreased
45,871
-26.1%
$971,5480.0%$17.51
0
2023-Q3
Increased
62,112
+774.0%
$1.3M0.0%$16.98
41
2023-Q2
Increased
7,107
+294.8%
$132,4740.0%$16.61
36
2023-Q1
Decreased
1,800
-96.3%
$37,4400.0%$16.07
0
2022-Q4
New
48,547
-
$996,6700.0%$15.56
35
2022-Q2
Exited
0
-100.0%
$00.0%$14.89
0
2022-Q1
Decreased
63,085
-30.1%
$1.4M0.0%$15.85
0
2021-Q4
Decreased
90,282
-97.1%
$2M0.0%$15.96
0
2021-Q3
Increased
3.1M
+42.6%
$69.5M0.9%$15.85
56
2021-Q2
Increased
2.2M
+173.9%
$48.8M0.6%$15.76
67
2021-Q1
Decreased
804,928
-75.7%
$17.8M0.3%$15.63
0
2020-Q4
Increased
3.3M
+398.6%
$73.8M1.0%$15.60
75
2020-Q3
New
664,415
-
$14.4M0.2%$15.10
46
2020-Q1
Exited
0
-100.0%
$00.0%$13.97
0
2019-Q4
New
1,059
-
$24,0000.0%$15.40
26

Other major holders of BKLN: BNP PARIBAS FINANCIAL MARKETS, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, PRUDENTIAL PLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used